Related Experiment Video
Updated: Aug 29, 2026

Measurement of γHV68 Infection in Mice
Published on: November 22, 2011
Insights
Hepatitis G virus (HGV) often co-infects with Hepatitis C virus (HCV) in chronic liver disease patients. Treatment effectiveness varied, with financial capacity influencing therapy choices.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Chronic viral hepatitis (CVH) management requires understanding co-infections.
- Hepatitis G virus (HGV) and Hepatitis C virus (HCV) are significant causes of liver disease.
Observation:
- HGV RNA was detected in 32 patients; HGV and HCV RNA co-infection occurred in 77 patients with CVH.
- Intravenous drug use was a common transmission route for HGV/HCV co-infection.
- Parenteral procedures and blood transfusions were noted routes for HGV monoinfection.
Findings:
- HGV monoinfection presented with elevated transaminases and hyperbilirubinemia.
- These biochemical markers were absent in the HGV + HCV co-infection group.
- A 3-month antiviral therapy showed positive results in 5 out of 13 treated patients with HGV + HCV infection.
Implications:
- HGV co-infection with HCV is more prevalent than HGV monoinfection in CVH.
- Distinct clinical presentations differentiate HGV monoinfection from HGV/HCV co-infection.
- Therapeutic strategies for HGV and HCV should consider patient financial constraints.
Aim:
To characterize the clinical and laboratory manifestations in patients with HG viral infection frequently concurrent with chronic HCV infection and the potentialities of their treatment.
Materials And Methods:
109 patients with suspected chronic hepatic disease were examined. The markers of HGV, HCV, HBV, and TTV infections were determined. The possible factors of infection, biochemical parameters, and the efficiency of antiviral therapy were assessed.
Results:
Hepatitis G virus RNK was detected in 32 cases, a combined variant of hepatitis G + C viruses RNA was found in 77 patients with chronic viral hepatitis (CVH). Among the presumed routes of contamination in the mixed variant of CVH, there were most common intravenous injection of narcotic drugs; in monoinfection (HGV), there were parenteral interventions in medical facilities and blood transfusion. Antiviral treatment of 13 patients with chronic HGV + HCV infection yielded a positive result in 5 patients after 3-month therapy.
Conclusion:
In patients with CVH, HG virus infection was more frequently observed in combination with CVHC, less frequently as monoinfection. In HG virus monoinfection, biochemical studies revealed the enhanced activity of transaminases and hyperbilirubinemia that was absent in the mixed variant of HGV + HCV. The financial capacities of patients should be taken into account while choosing therapy.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
Related Concept Videos
Viral Hepatitis I: Introduction
Respiratory Syncytial Virus Disease
Cytomegalovirus Disease
Genital Herpes
Influenza
Hepatitis